{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:56:02Z","timestamp":1791186962509,"version":"4.1.0"},"reference-count":36,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Health Science Reports"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Psoriasis can lead to the occurrence of various chronic diseases. However, the detailed reports of psoriasis before and after COVID\u201019 are limited. The present study aimed to investigate the global prevalence, incidence, and death and disability adjusted life years (DALYs) of psoriasis with age and sex differences from 1990 to 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were extracted from the Global Burden of Disease (GBD) Study 2021. Our research combined multiple models such as estimated annual percentage change (EAPC), joinpoint regression (JPR), age\u2010period\u2010cohort (APC), Bayesian age\u2010period\u2010cohort (BAPC) to comprehensively and in\u2010depth describe the global epidemiological characteristics of psoriasis and its associations with COVID\u201019 and respiratory infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The ASRs of prevalence, incidence and DALYs were 516, 62, and 44.4 per 100,000 with increased change percentage, 8% (95% UI: 7.7%\u20138.3%), 8.8% (95% UI: 8.5%\u20139%) and 8% (95% UI: 7%\u20139%), respectively. Western Europe, Andean Latin America, and High\u2010income North America had highest ASRs of prevalence (1155.9, 1018.7, 975.7 per 100,000), incidence (115.3, 105, 103.5 per 100,000), and DALYs (99.8, 88.4, 83.1 per 100,000), while the most changing rate was in East Asia (30.8%, 25.6%, 31%), North Africa and Middle East (27%, 21.4%, 26.5%) and Southeast Asia (20.6%, 16.6%, 20.9%). Moreover, the annual average rate of psoriasis changed significantly before and after the COVID\u201019 pandemic with different ages and sex. And the prevalence for psoriasis was negatively correlated with COVID\u201019 (\n                      <jats:italic>R<\/jats:italic>\n                      \u2009=\u2009\u22120.39,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and lower respiratory infections (\n                      <jats:italic>R<\/jats:italic>\n                      \u2009=\u2009\u22120.67,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Finally, the trend of psoriasis will keep increasing by 2040.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The prevalence, incidence, and DALYs for psoriasis after COVID\u201019 will still increase leading to a severe issue that urgently needs to be solved around world. Our present study integrated with the models and analysis will provide an important theoretical foundation for formulating measures to prevent and treat psoriasis on a global scale in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hsr2.73095","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:32:36Z","timestamp":1787808756000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Global Burden and Temporal Trends of Psoriasis, 1990\u20132021: Implications From the COVID\u201019 Pandemic"],"prefix":"10.1002","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5866-7720","authenticated-orcid":false,"given":"Yunda","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Dermatology The Fourth Medical Center, PLA General Hospital Beijing China"},{"name":"The Outpatient Department of 61889 Military Hospital Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[{"name":"Research Center for Tissue Repair and Regeneration Affiliated to the Medical Innovation Research Department, PLA General Hospital and PLA Medical College Beijing China"},{"name":"PLA Key Laboratory of Tissue Repair and Regenerative Medicine and Beijing Key Research Laboratory of Skin Injury, Repair, and Regeneration Beijing China"},{"name":"Research Unit of Trauma Care, Tissue Repair, and Regeneration Chinese Academy of Medical Sciences Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglu","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Dermatology The Fourth Medical Center, PLA General Hospital Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology The Fourth Medical Center, PLA General Hospital Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Ma","sequence":"additional","affiliation":[{"name":"Research Center for Tissue Repair and Regeneration Affiliated to the Medical Innovation Research Department, PLA General Hospital and PLA Medical College Beijing China"},{"name":"PLA Key Laboratory of Tissue Repair and Regenerative Medicine and Beijing Key Research Laboratory of Skin Injury, Repair, and Regeneration Beijing China"},{"name":"Research Unit of Trauma Care, Tissue Repair, and Regeneration Chinese Academy of Medical Sciences Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Fu","sequence":"additional","affiliation":[{"name":"Research Center for Tissue Repair and Regeneration Affiliated to the Medical Innovation Research Department, PLA General Hospital and PLA Medical College Beijing China"},{"name":"PLA Key Laboratory of Tissue Repair and Regenerative Medicine and Beijing Key Research Laboratory of Skin Injury, Repair, and Regeneration Beijing China"},{"name":"Research Unit of Trauma Care, Tissue Repair, and Regeneration Chinese Academy of Medical Sciences Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7766-5412","authenticated-orcid":false,"given":"Siming","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Dermatology The Fourth Medical Center, PLA General Hospital Beijing China"},{"name":"Research Center for Tissue Repair and Regeneration Affiliated to the Medical Innovation Research Department, PLA General Hospital and PLA Medical College Beijing China"},{"name":"PLA Key Laboratory of Tissue Repair and Regenerative Medicine and Beijing Key Research Laboratory of Skin Injury, Repair, and Regeneration Beijing China"},{"name":"Research Unit of Trauma Care, Tissue Repair, and Regeneration Chinese Academy of Medical Sciences Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.05.008"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1092668"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32549-6"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-02846-z"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/20406223231168488"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115078"},{"key":"e_1_2_14_8_1","unstructured":"Global Regional and National Incidence and Mortality Burden of Non\u2010COVID\u201019 Lower Respiratory Infections and Aetiologies 1990\u20102021: A Systematic Analysis From the Global Burden of Disease Study 2021.Lancet Infectious Diseases.24 no.9(2024): 974\u20131002."},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncrna.2024.08.007"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003024"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15113"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13632"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15414"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18531"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.10.019"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20055"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-069679"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/pai.14271"},{"key":"e_1_2_14_19_1","unstructured":"GBD 2019 Cancer Risk Factors Collaborators \u201cThe Global Burden of Cancer Attributable to Risk Factors 2010\u201019: A Systematic Analysis for the Global Burden of Disease Study 2019 \u201dLancet400 no.10352(2022): 563\u2013591."},{"key":"e_1_2_14_20_1","unstructured":"GBD 2019 Respiratory Tract Cancers Collaborators \u201cGlobal Regional and National Burden of Respiratory Tract Cancers and Associated Risk Factors From 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019 \u201dLancet Respiratory Medicine9 no.9(2021): 1030\u20131049."},{"key":"e_1_2_14_21_1","unstructured":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators \u201cGlobal Regional and National Incidence Prevalence and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and Territories 1990\u20102017: A Systematic Analysis for the Global Burden of Disease Study 2017 \u201dLancet392 no.10159(2018): 1789\u20131858."},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30677-2"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2022.2074535"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-024-08991-7"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.139"},{"key":"e_1_2_14_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.09.001"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.585634"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2763-3"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16083"},{"key":"e_1_2_14_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13854"},{"key":"e_1_2_14_31_1","first-page":"23","article-title":"The Unmet Need for Clinical Guidelines on the Management of Patients With Plaque Psoriasis in Africa and the Middle East","volume":"10","author":"Steinhoff M.","year":"2020","journal-title":"Psoriasis (Auckland, NZ)"},{"key":"e_1_2_14_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17255"},{"key":"e_1_2_14_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19169"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S421394"},{"key":"e_1_2_14_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0275293"},{"key":"e_1_2_14_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8040728"},{"key":"e_1_2_14_37_1","unstructured":"GBD 2021 Diseases and Injuries Collaborators \u201cGlobal Incidence Prevalence Years Lived With Disability (YLDs) Disability\u2010Adjusted Life\u2010Years (DALYs) and Healthy Life Expectancy (HALE) for 371 Diseases and Injuries in 204 Countries and Territories and 811 Subnational Locations 1990\u20102021: A Systematic Analysis for the Global Burden of Disease Study 2021 \u201dLancet403 no.10440(2024): 2133\u20132161."}],"container-title":["Health Science Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hsr2.73095","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hsr2.73095","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hsr2.73095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:41:08Z","timestamp":1791186068000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hsr2.73095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1002\/hsr2.73095"],"URL":"https:\/\/doi.org\/10.1002\/hsr2.73095","archive":["Portico"],"relation":{},"ISSN":["2398-8835","2398-8835"],"issn-type":[{"value":"2398-8835","type":"print"},{"value":"2398-8835","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"2025-08-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e73095"}}